Markets:

Overview

News

Currencies

International

Treasuries

Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

106.90 +1.94 (+1.85%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nuvalent, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024 ↗

May 09, 2024

NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Recap: Nuvalent Q4 Earnings ↗

February 27, 2024

Via Benzinga

Recap: Nuvalent Q3 Earnings ↗

November 14, 2023

Via Benzinga

7 Biotech Stocks to Get In Now Before Investors Catch On ↗

October 23, 2023

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

Via InvestorPlace

Why Nuvalent Stock Tanked on Tuesday ↗

October 17, 2023

The dilution monster stalked the company following the announcement of a new capital-raising effort.

Via The Motley Fool

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

October 06, 2023

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...

Via Benzinga

Where Nuvalent Stands With Analysts ↗

October 05, 2023

Via Benzinga

Why Nuvalent Stock Was Soaring Wednesday ↗

October 04, 2023

The company reported preliminary data on a non-small cell lung cancer therapy.

Via The Motley Fool

Expert Ratings for Nuvalent ↗

August 08, 2023

Via Benzinga

Why Nuvalent Stock Skyrocketed 35% This Week ↗

October 05, 2023

Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 04, 2023

Via Benzinga

Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold ↗

September 27, 2023

Stifel initiated coverage on Nuvalent Inc (NASDAQ: NUVL), recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients,...

Via Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 18, 2023

Gainers

Via Benzinga

Nuvalent: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗

September 18, 2023

U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

7 A-Rated Biotech Stocks for Your August Buy List ↗

August 17, 2023

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying ↗

November 08, 2022

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying ↗

November 04, 2022

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

October 31, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023 ↗

January 18, 2023

Via Benzinga

Nasdaq Climbs 275 Points; S&P 500 Rises Over 2% ↗

October 28, 2022

U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday.

Via Benzinga

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗

October 31, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 28, 2022

Gainers

Via Benzinga

Stocks Boast Midday Gains On Road To Big Weekly Weekly Wins ↗

October 28, 2022

Wall Street is brushing off a dismal earnings report from Amazon.com, and opting to favor unsurprising inflation and steady consumer spending data.

Via Talk Markets

Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

October 28, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.

Via Benzinga

Recent IPO Stock Nuvalent Is Flirting With A Record High On A Tricky Cancer Win ↗

October 28, 2022

Nuvalent is targeting a specific genetic mutation in lung cancer.

Via Investor's Business Daily

Dow Jumps 600 Points; Crude Oil Down Over 1% ↗

October 28, 2022

U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.